Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06150599 · ClinicalTrials.gov registry record · NA
Sacral Neuromodulation for Chronic Pelvic Pain
A NA study of Chronic Pelvic Pain Syndrome, sponsored by Corewell Health East.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06150599: Recruiting NA study of Chronic Pelvic Pain Syndrome, sponsored by Corewell Health East.
NCT06150599 is a NA study of Chronic Pelvic Pain Syndrome that is actively recruiting participants, run by Corewell Health East. The registered enrollment target is 25 participants, below the 194-participant average among 11 other Chronic Pelvic Pain Syndrome trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06150599, a NA study of Chronic Pelvic Pain Syndrome, is actively recruiting participants, sponsored by Corewell Health East.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Sacral neuromodulation (SNM) is a safe, effective, and minimally invasive FDA approved treatment for urinary and fecal incontinence, urinary frequency, urgency, and urinary retention. In this study we are assessing the effectiveness of sacral neuromodulation in women with suffering from chronic pelvic pain (CPP), through a single device implant procedure.
Primary Outcome
The VAS is a validated tool to determine patient perceived pain. VAS is scored from 0-10, where 0 = no pain and 10 = worst possible pain. The value at Visit 4 (10 weeks post-implant) minus the value at Visit 2 (baseline, 2 weeks post-implant) will be used to calculate change. Negative numbers indicate an improvement in pain, and positive numbers indicate a worsening pain
Conditions Studied
Interventions
- DEVICE Sacral neuromodulation
Study Locations (1)
Michigan
- Corewell Health William Beaumont University Hospital - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-06-30 |
| Est. Completion | 2028-12-01 |
| Phase | NA |
What NCT06150599 shows while recruiting
NCT06150599 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 194-participant average among 11 other Chronic Pelvic Pain Syndrome trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Chronic Pelvic Pain Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Sacral neuromodulation is the first listed.
NCT06150599 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06150599 about?
NCT06150599 is a clinical study titled "Sacral Neuromodulation for Chronic Pelvic Pain". Sacral neuromodulation (SNM) is a safe, effective, and minimally invasive FDA approved treatment for urinary and fecal incontinence, urinary frequency, urgency, and urinary retention. In this study we are assessing the effectiveness of sacral neuromodulation in women with suffering from chronic pelv...
What is the current status of trial NCT06150599?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-06-30. Estimated completion is 2028-12-01.
What conditions does trial NCT06150599 study?
This clinical trial studies the following conditions: Chronic Pelvic Pain Syndrome.
What interventions are being tested in trial NCT06150599?
The interventions under investigation include: Sacral neuromodulation (DEVICE).
Who is sponsoring clinical trial NCT06150599?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06150599 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pelvic Pain Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06150599's enrollment target sits among peer trials
25 11th of 11 higher than 1 of 11 other Chronic Pelvic Pain Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pelvic Pain Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prospective Evaluation of Effectiveness and Safety of Closed-Loop Spinal Cord Stimulation in Treating Patients With Chronic Pelvic Pain
RECRUITING · NA
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
RECRUITING · NA
-
National Program to Overcome Pelvic Pain studY (POPPY)
RECRUITING · NA
-
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
RECRUITING · NA
-
Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI